Authors:
Sanson, M
Napolitano, M
Yaya, R
Keime-Guibert, F
Broet, P
Hoang-Xuan, K
Delattre, JY
Citation: M. Sanson et al., Second line chemotherapy with docetaxel in patients with recurrent malignant glioma: a phase II study, J NEURO-ONC, 50(3), 2000, pp. 245-249
Authors:
Rojas, I
Graus, F
Keime-Guibert, F
Rene, R
Delattre, JY
Ramon, JM
Dalmau, J
Posner, JB
Citation: I. Rojas et al., Long-term clinical outcome of paraneoplastic cerebellar degeneration and anti-Yo antibodies, NEUROLOGY, 55(5), 2000, pp. 713-715
Authors:
Keime-Guibert, F
Graus, F
Fleury, A
Rene, R
Honnorat, J
Broet, P
Delattre, JY
Citation: F. Keime-guibert et al., Treatment of paraneoplastic neurological syndromes with antineuronal antibodies (Anti-Hu, Anti-Yo) with a combination of immunoglobulins, cyclophosphamide, and methylprednisolone, J NE NE PSY, 68(4), 2000, pp. 479-482
Authors:
Napolitano, M
Keime-Guibert, F
Monjour, A
Lafitte, C
Ameri, A
Cornu, P
Broet, P
Delattre, JY
Citation: M. Napolitano et al., Treatment of supratentorial glioblastoma multiforme with radiotherapy and a combination of BCNU and tamoxifen: a phase II study, J NEURO-ONC, 45(3), 1999, pp. 229-235
Authors:
Keime-Guibert, F
Graus, F
Broet, P
Rene, R
Molinuevo, JL
Ascaso, C
Delattre, JY
Citation: F. Keime-guibert et al., Clinical outcome of patients with anti-Hu-associated encephalomyelitis after treatment of the tumor, NEUROLOGY, 53(8), 1999, pp. 1719-1723